As expected, improved CD8+ cytotoxic T cells and suppressed Tregs in CD4+ T cells were observed in PLGA-R837@Cat with CTLA-4 antibody-treated tumor tissues compared to other groups (Figure 3E). This evidence concerns the gene CTLA4 and neoplasm.